Oncology Pharma Inc. that it has retained the services of Mr. James Smith, CPA as its new Chief Financial Officer. Mr. James Smith, CPA is a seasoned executive officer with experience encompassing multiple public and private companies across a variety of industries. His prior experience includes CEO and/or CFO in two fully reporting SEC registrants as well as numerous OTC Pink Sheet companies in either the CFO, outside accountant or CEO capacities. In addition, during his employment with two national accounting firms and in his own CPA firm practice, Mr. Smith has worked with multiple Family Offices and investors in assisting them with their operations, capital placement, organizational strategy and structure, with an emphasis on tax and estate planning. Oncology Pharma is pleased to welcome Mr. Smith aboard as the Company is working towards expanding its portfolio and financing.